Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.72
Delayed Data
As of 3:59pm ET
 +0.03 / +0.64%
Today’s Change
2.80
Today|||52-Week Range
7.80
-6.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.007.0M10.8M13.7M
 
 
 
 
Cost of Goods Sold0.00--495.0K6.6M
 
 
 
Depreciation And Amortization35.0K54.0K306.0K596.0K
 
 
 
 
 
 
Operating ExpensesGross Income-35.0K--10.0M6.4M
 
 
 
 
General Expenses27.0M53.0M121.3M117.5M
 
 
 
 
 
Research And Development20.0M33.7M51.4M36.6M
 
 
 
 
 
Total Operating Expenses27.1M53.1M122.1M124.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.1M-46.1M-111.2M-111.1M
 
 
 
 
 
Extraordinary Charge0.00-1.0M0.00-1.1M
 
 
 
Interest Expense On Debt------11.4M
 
 
Other Expenses1.7M161.0K121.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.4M-46.7M-110.8M-123.1M
 
 
 
 
 
Income Taxes0.000.00-700.0K-90.0K
 
 
 
Extraordinary Items2.6M0.000.000.00
 
 
Net Income-25.4M-46.7M-111.5M-123.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS71.6M81.0M91.0M103.9M
 
 
 
 
 
Shares To Calculate EPS Diluted71.6M81.0M91.0M103.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.32-$0.58-$1.23-$1.19
 
 
 
 
 
EPS Diluted-$0.35-$0.58-$1.23-$1.19